PubMed

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial.

de Azambuja E, McCaskill-Stevens W, Francis P, Quinaux E, Crown JP, Vicente M, Giuliani R, Nordenskjöld B, Gutiérez J, Andersson M, Vila MM, Jakesz R, Demol J, Dewar J, Santoro A, Lluch A, Olsen S, Gelber RD, Di Leo A, Piccart-Gebhart M.

Breast Cancer Res Treat. 2009 Sep 3. [Epub ahead of print]PMID: 19731015 [PubMed - as supplied by publisher]Related articles

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.

BIG 1-98 Collaborative Group, Mouridsen H, Giobbie-Hurder A, Goldhirsch A, Thürlimann B, Paridaens R, Smith I, Mauriac L, Forbes JF, Price KN, Regan MM, Gelber RD, Coates AS.

N Engl J Med. 2009 Aug 20;361(8):766-76.PMID: 19692688 [PubMed - indexed for MEDLINE]Related articles

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.

Viale G, Giobbie-Hurder A, Gusterson BA, Maiorano E, Mastropasqua MG, Sonzogni A, Mallon E, Colleoni M, Castiglione-Gertsch M, Regan MM, Price KN, Brown RW, Golouh R, Crivellari D, Karlsson P, Ohlschlegel C, Gelber RD, Goldhirsch A, Coates AS.

Ann Oncol. 2009 Jul 24. [Epub ahead of print]PMID: 19633051 [PubMed - as supplied by publisher]Related articles

The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial.

Desmedt C, Giobbie-Hurder A, Neven P, Paridaens R, Christiaens MR, Smeets A, Lallemand F, Haibe-Kains B, Viale G, Gelber RD, Piccart M, Sotiriou C.

BMC Med Genomics. 2009 Jul 2;2:40.PMID: 19573224 [PubMed - in process]Related articlesFree article

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.

Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn HJ; Panel members.

Ann Oncol. 2009 Aug;20(8):1319-29. Epub 2009 Jun 17.PMID: 19535820 [PubMed - indexed for MEDLINE]Related articlesFree article

Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer.

Giobbie-Hurder A, Price KN, Gelber RD; International Breast Cancer Study Group; BIG 1-98 Collaborative Group.

Clin Trials. 2009 Jun;6(3):272-87.PMID: 19528136 [PubMed - indexed for MEDLINE]Related articles

Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study.

Grant CS, Ingle JN, Suman VJ, Dumesic DA, Wickerham DL, Gelber RD, Flynn PJ, Weir LM, Intra M, Jones WO, Perez EA, Hartmann LC.

J Clin Oncol. 2009 Aug 1;27(22):3620-6. Epub 2009 Jun 1.PMID: 19487378 [PubMed - indexed for MEDLINE]Related articles

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

Gelber RD, Aebi S.

N Engl J Med. 2009 May 28;360(22):2367; author reply 2369-70. No abstract available. PMID: 19484813 [PubMed - indexed for MEDLINE]Related articles

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.

Rabaglio M, Sun Z, Price KN, Castiglione-Gertsch M, Hawle H, Thürlimann B, Mouridsen H, Campone M, Forbes JF, Paridaens RJ, Colleoni M, Pienkowski T, Nogaret JM, Láng I, Smith I, Gelber RD, Goldhirsch A, Coates AS; BIG 1-98 Collaborative and International Breast Cancer Study Groups.

Ann Oncol. 2009 Sep;20(9):1489-98. Epub 2009 May 27.PMID: 19474112 [PubMed - indexed for MEDLINE]Related articles

The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.

Colleoni M, Sun Z, Martinelli G, Basser RL, Coates AS, Gelber RD, Green MD, Peccatori F, Cinieri S, Aebi S, Viale G, Price KN, Goldhirsch A; International Breast Cancer Study Group.

Ann Oncol. 2009 Aug;20(8):1344-51. Epub 2009 May 25.PMID: 19468030 [PubMed - indexed for MEDLINE]Related articles

Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial.

Dowsett M, Procter M, McCaskill-Stevens W, de Azambuja E, Dafni U, Rueschoff J, Jordan B, Dolci S, Abramovitz M, Stoss O, Viale G, Gelber RD, Piccart-Gebhart M, Leyland-Jones B.

J Clin Oncol. 2009 Jun 20;27(18):2962-9. Epub 2009 Apr 13.PMID: 19364966 [PubMed - indexed for MEDLINE]Related articles

Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

Maiorano E, Regan MM, Viale G, Mastropasqua MG, Colleoni M, Castiglione-Gertsch M, Price KN, Gelber RD, Goldhirsch A, Coates AS.

Breast Cancer Res Treat. 2009 Mar 12. [Epub ahead of print]PMID: 19280340 [PubMed - as supplied by publisher]Related articles

Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer.

Sun Z, Goldhirsch A, Price KN, Colleoni M, Ravaioli A, Simoncini E, Campbell I, Gelber RD, Towler M.

Breast. 2009 Apr;18(2):84-8. Epub 2009 Feb 24.PMID: 19243946 [PubMed - indexed for MEDLINE]Related articles

A small sample study of the STEPP approach to assessing treatment-covariate interactions in survival data.

Bonetti M, Zahrieh D, Cole BF, Gelber RD.

Stat Med. 2009 Apr 15;28(8):1255-68.PMID: 19170050 [PubMed - indexed for MEDLINE]Related articles

Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.

Pagani O, Price KN, Gelber RD, Castiglione-Gertsch M, Holmberg SB, Lindtner J, Thürlimann B, Collins J, Fey MF, Coates AS, Goldhirsch A; International Breast Cancer Study Group (IBCSG).

Breast Cancer Res Treat. 2009 Sep;117(2):319-24. Epub 2009 Jan 10.PMID: 19137426 [PubMed - indexed for MEDLINE]Related articles

Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.

Gianni L, Gelber S, Ravaioli A, Price KN, Panzini I, Fantini M, Castiglione-Gertsch M, Pagani O, Simoncini E, Gelber RD, Coates AS, Goldhirsch A.

Eur J Cancer. 2009 Mar;45(4):561-71. Epub 2008 Dec 4.PMID: 19062268 [PubMed - indexed for MEDLINE]Related articles

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.

Viale G, Giobbie-Hurder A, Regan MM, Coates AS, Mastropasqua MG, Dell'Orto P, Maiorano E, MacGrogan G, Braye SG, Ohlschlegel C, Neven P, Orosz Z, Olszewski WP, Knox F, Thürlimann B, Price KN, Castiglione-Gertsch M, Gelber RD, Gusterson BA, Goldhirsch A; Breast International Group Trial 1-98.

J Clin Oncol. 2008 Dec 1;26(34):5569-75. Epub 2008 Nov 3.PMID: 18981464 [PubMed - indexed for MEDLINE]Related articlesFree article

Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.

Pagani O, Gelber S, Simoncini E, Castiglione-Gertsch M, Price KN, Gelber RD, Holmberg SB, Crivellari D, Collins J, Lindtner J, Thürlimann B, Fey MF, Murray E, Forbes JF, Coates AS, Goldhirsch A; International Breast Cancer Study Group.

Breast Cancer Res Treat. 2009 Aug;116(3):491-500. Epub 2008 Oct 25.PMID: 18953651 [PubMed - indexed for MEDLINE]Related articles

Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.

Colleoni M, Bagnardi V, Rotmensz N, Gelber RD, Viale G, Pruneri G, Veronesi P, Torrisi R, Cardillo A, Montagna E, Campagnoli E, Luini A, Intra M, Galimberti V, Scarano E, Peruzzotti G, Goldhirsch A.

Breast Cancer Res Treat. 2009 Jul;116(2):359-69. Epub 2008 Oct 22.PMID: 18941889 [PubMed - indexed for MEDLINE]Related articles

Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables.

Anderson JR, Cain KC, Gelber RD.

J Clin Oncol. 2008 Aug 20;26(24):3913-5. No abstract available. PMID: 18711176 [PubMed - indexed for MEDLINE]Related articles

Another STEPP in the right direction.

Bonetti M, Cole BF, Gelber RD.

J Clin Oncol. 2008 Aug 1;26(22):3813-4; author reply 3814-5. No abstract available. PMID: 18669475 [PubMed - indexed for MEDLINE]Related articles

A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.

Wapnir IL, Aebi S, Geyer CE, Zahrieh D, Gelber RD, Anderson SJ, Robidoux A, Bernhard J, Maibach R, Castiglione-Gertsch M, Coates AS, Piccart MJ, Clemons MJ, Costantino JP, Wolmark N; IBCSG; BIG; NSABP.

Clin Breast Cancer. 2008 Jun;8(3):287-92.PMID: 18650162 [PubMed - indexed for MEDLINE]Related articlesFree article

Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial.

Pestalozzi BC, Francis P, Quinaux E, Dolci S, Azambuja E, Gelber RD, Viale G, Balil A, Andersson M, Nordenskjöld B, Gnant M, Gutierrez J, Láng I, Crown JP, Piccart-Gebhart M; BIG 02-98 Collaborative Group.

Ann Oncol. 2008 Nov;19(11):1837-41. Epub 2008 Jun 18.PMID: 18562328 [PubMed - indexed for MEDLINE]Related articlesFree article

Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials.

Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, Gelber RD, Holmberg SB, Lindtner J, Snyder R, Thürlimann B, Murray E, Viale G, Castiglione-Gertsch M, Coates AS, Goldhirsch A; International Breast Cancer Study Group.

J Clin Oncol. 2008 Jun 20;26(18):3006-14. Epub 2008 May 5.PMID: 18458044 [PubMed - indexed for MEDLINE]Related articles

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.

Gruber G, Cole BF, Castiglione-Gertsch M, Holmberg SB, Lindtner J, Golouh R, Collins J, Crivellari D, Thürlimann B, Simoncini E, Fey MF, Gelber RD, Coates AS, Price KN, Goldhirsch A, Viale G, Gusterson BA; International Breast Cancer Study Group.

Ann Oncol. 2008 Aug;19(8):1393-401. Epub 2008 Apr 2.PMID: 18385202 [PubMed - indexed for MEDLINE]Related articlesFree article

Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.

Viale G, Regan MM, Maiorano E, Mastropasqua MG, Golouh R, Perin T, Brown RW, Kovács A, Pillay K, Ohlschlegel C, Braye S, Grigolato P, Rusca T, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS.

J Clin Oncol. 2008 Mar 20;26(9):1404-10.PMID: 18349391 [PubMed - indexed for MEDLINE]Related articles

Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.

Crivellari D, Sun Z, Coates AS, Price KN, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens RJ, Castiglione-Gertsch M, Gelber RD, Colleoni M, Láng I, Del Mastro L, Gladieff L, Rabaglio M, Smith IE, Chirgwin JH, Goldhirsch A.

J Clin Oncol. 2008 Apr 20;26(12):1972-9. Epub 2008 Mar 10.PMID: 18332471 [PubMed - indexed for MEDLINE]Related articles

Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?

Regan MM, Pagani O, Walley B, Torrisi R, Perez EA, Francis P, Fleming GF, Price KN, Thürlimann B, Maibach R, Castiglione-Gertsch M, Coates AS, Goldhirsch A, Gelber RD; SOFT/TEXT/PERCHE Steering Committee; International Breast Cancer Study Group.

Ann Oncol. 2008 Jul;19(7):1231-41. Epub 2008 Mar 5.PMID: 18325918 [PubMed - indexed for MEDLINE]Related articlesFree article

Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial.

Untch M, Gelber RD, Jackisch C, Procter M, Baselga J, Bell R, Cameron D, Bari M, Smith I, Leyland-Jones B, de Azambuja E, Wermuth P, Khasanov R, Feng-Yi F, Constantin C, Mayordomo JI, Su CH, Yu SY, Lluch A, Senkus-Konefka E, Price C, Haslbauer F, Suarez Sahui T, Srimuninnimit V, Colleoni M, Coates AS, Piccart-Gebhart MJ, Goldhirsch A; HERA Study Team.

Ann Oncol. 2008 Jun;19(6):1090-6. Epub 2008 Feb 21.PMID: 18296421 [PubMed - indexed for MEDLINE]Related articlesFree article

Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.

Thürlimann B, Price KN, Gelber RD, Holmberg SB, Crivellari D, Colleoni M, Collins J, Forbes JF, Castiglione-Gertsch M, Coates AS, Goldhirsch A.

Breast Cancer Res Treat. 2009 Jan;113(1):137-44. Epub 2008 Feb 8.PMID: 18259856 [PubMed - indexed for MEDLINE]Related articles

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

Viale G, Regan MM, Mastropasqua MG, Maffini F, Maiorano E, Colleoni M, Price KN, Golouh R, Perin T, Brown RW, Kovács A, Pillay K, Ohlschlegel C, Gusterson BA, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Coates AS; International Breast Cancer Study Group.

J Natl Cancer Inst. 2008 Feb 6;100(3):207-12. Epub 2008 Jan 29.PMID: 18230798 [PubMed - indexed for MEDLINE]Related articlesFree article

Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.

Francis P, Crown J, Di Leo A, Buyse M, Balil A, Andersson M, Nordenskjöld B, Lang I, Jakesz R, Vorobiof D, Gutiérrez J, van Hazel G, Dolci S, Jamin S, Bendahmane B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Piccart-Gebhart M; BIG 02-98 Collaborative Group.

J Natl Cancer Inst. 2008 Jan 16;100(2):121-33. Epub 2008 Jan 8. Erratum in: J Natl Cancer Inst. 2008 Nov 19;100(22):1655. PMID: 18182617 [PubMed - indexed for MEDLINE]Related articlesFree article

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Clarke M, Coates AS, Darby SC, Davies C, Gelber RD, Godwin J, Goldhirsch A, Gray R, Peto R, Pritchard KI, Wood WC.

Lancet. 2008 Jan 5;371(9606):29-40. Review.PMID: 18177773 [PubMed - indexed for MEDLINE]Related articles

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

Rasmussen BB, Regan MM, Lykkesfeldt AE, Dell'Orto P, Del Curto B, Henriksen KL, Mastropasqua MG, Price KN, Méry E, Lacroix-Triki M, Braye S, Altermatt HJ, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Gusterson BA, Thürlimann B, Coates AS, Viale G; BIG 1-98 Collaborative and International Breast Cancer Study Groups.

Lancet Oncol. 2008 Jan;9(1):23-8. Epub 2007 Dec 20.PMID: 18083065 [PubMed - indexed for MEDLINE]Related articles

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.

Bernhard J, Zahrieh D, Zhang JJ, Martinelli G, Basser R, Hürny C, Forbes JF, Aebi S, Yeo W, Thürlimann B, Green MD, Colleoni M, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Coates AS; International Breast Cancer Study Group.

Br J Cancer. 2008 Jan 15;98(1):25-33. Epub 2007 Nov 27.PMID: 18043579 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.

Mouridsen H, Keshaviah A, Coates AS, Rabaglio M, Castiglione-Gertsch M, Sun Z, Thürlimann B, Mauriac L, Forbes JF, Paridaens R, Gelber RD, Colleoni M, Smith I, Price KN, Goldhirsch A.

J Clin Oncol. 2007 Dec 20;25(36):5715-22. Epub 2007 Nov 12.PMID: 17998546 [PubMed - indexed for MEDLINE]Related articles

Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy.

Colleoni M, Viale G, Zahrieh D, Bottiglieri L, Gelber RD, Veronesi P, Balduzzi A, Torrisi R, Luini A, Intra M, Dellapasqua S, Cardillo A, Ghisini R, Peruzzotti G, Goldhirsch A.

Ann Oncol. 2008 Mar;19(3):465-72. Epub 2007 Nov 6.PMID: 17986623 [PubMed - indexed for MEDLINE]Related articlesFree article

Using clinical trial data to tailor adjuvant treatments for individual patients.

Regan MM, Gelber RD; International Breast Cancer Study Group (IBCSG) and the Breast International Group (BIG).

Breast. 2007 Dec;16 Suppl 2:S98-104. Epub 2007 Aug 23.PMID: 17719227 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

Viale G, Regan MM, Maiorano E, Mastropasqua MG, Dell'Orto P, Rasmussen BB, Raffoul J, Neven P, Orosz Z, Braye S, Ohlschlegel C, Thürlimann B, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS.

J Clin Oncol. 2007 Sep 1;25(25):3846-52. Epub 2007 Aug 6.PMID: 17679725 [PubMed - indexed for MEDLINE]Related articles

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn HJ; 10th St. Gallen conference.

Ann Oncol. 2007 Jul;18(7):1133-44. Review. Erratum in: Ann Oncol. 2007 Nov;18(11):1917. PMID: 17675394 [PubMed - indexed for MEDLINE]Related articlesFree article

Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.

Suter TM, Procter M, van Veldhuisen DJ, Muscholl M, Bergh J, Carlomagno C, Perren T, Passalacqua R, Bighin C, Klijn JG, Ageev FT, Hitre E, Groetz J, Iwata H, Knap M, Gnant M, Muehlbauer S, Spence A, Gelber RD, Piccart-Gebhart MJ.

J Clin Oncol. 2007 Sep 1;25(25):3859-65. Epub 2007 Jul 23.PMID: 17646669 [PubMed - indexed for MEDLINE]Related articles

Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression.

Rocca A, Viale G, Gelber RD, Bottiglieri L, Gelber S, Pruneri G, Ghisini R, Balduzzi A, Pietri E, D'Alessandro C, Goldhirsch A, Colleoni M.

Cancer Chemother Pharmacol. 2008 May;61(6):965-71. Epub 2007 Jul 18.PMID: 17639392 [PubMed - indexed for MEDLINE]Related articles

Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.

Newell ML, Huang S, Fiore S, Thorne C, Mandelbrot L, Sullivan JL, Maupin R, Delke I, Watts DH, Gelber RD, Cunningham CK; PACTG 316 Study Team.

BMC Infect Dis. 2007 Jun 20;7:60.PMID: 17584491 [PubMed - indexed for MEDLINE]Related articlesFree article

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.

Hudis CA, Barlow WE, Costantino JP, Gray RJ, Pritchard KI, Chapman JA, Sparano JA, Hunsberger S, Enos RA, Gelber RD, Zujewski JA.

J Clin Oncol. 2007 May 20;25(15):2127-32.PMID: 17513820 [PubMed - indexed for MEDLINE]Related articles

Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.

Partridge A, Gelber S, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Winer E.

Eur J Cancer. 2007 Jul;43(11):1646-53. Epub 2007 May 18.PMID: 17512721 [PubMed - indexed for MEDLINE]Related articles

Problems with the progesterone receptor in practice?

Jordan VC, Gelber RD.

J Clin Oncol. 2007 May 20;25(15):1957-9. Epub 2007 Apr 23. No abstract available. PMID: 17452674 [PubMed - indexed for MEDLINE]Related articles

Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93.

International Breast Cancer Study Group, Colleoni M, Gelber S, Simoncini E, Pagani O, Gelber RD, Price KN, Castiglione-Gertsch M, Coates AS, Goldhirsch A.

Ann Oncol. 2007 Jul;18(7):1177-84. Epub 2007 Apr 11.PMID: 17429101 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer.

Karlsson P, Cole BF, Price KN, Coates AS, Castiglione-Gertsch M, Gusterson BA, Murray E, Lindtner J, Collins JP, Holmberg SB, Fey MF, Thürlimann B, Crivellari D, Forbes JF, Gelber RD, Goldhirsch A, Wallgren A.

J Clin Oncol. 2007 May 20;25(15):2019-26. Epub 2007 Apr 9.PMID: 17420511 [PubMed - indexed for MEDLINE]Related articles

Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.

Mauriac L, Keshaviah A, Debled M, Mouridsen H, Forbes JF, Thürlimann B, Paridaens R, Monnier A, Láng I, Wardley A, Nogaret JM, Gelber RD, Castiglione-Gertsch M, Price KN, Coates AS, Smith I, Viale G, Rabaglio M, Zabaznyi N, Goldhirsch A; BIG 1-98 Collaborative Group; International Breast Cancer Study Group.

Ann Oncol. 2007 May;18(5):859-67. Epub 2007 Feb 14.PMID: 17301074 [PubMed - indexed for MEDLINE]Related articlesFree article

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials.

Keshaviah A, Dellapasqua S, Rotmensz N, Lindtner J, Crivellari D, Collins J, Colleoni M, Thürlimann B, Mendiola C, Aebi S, Price KN, Pagani O, Simoncini E, Castiglione Gertsch M, Gelber RD, Coates AS, Goldhirsch A.

Ann Oncol. 2007 Apr;18(4):701-8. Epub 2007 Jan 20.PMID: 17237474 [PubMed - indexed for MEDLINE]Related articlesFree article